What complications and associated anatomic anomalies are linked to a markedly thick or overly long umbilical cord?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Large Umbilical Cord: Associated Problems and Anatomic Anomalies

An excessively long or thick umbilical cord significantly increases the risk of fetal thrombotic vasculopathy, intrauterine fetal demise, and fetal growth restriction through mechanisms of vascular stasis and thrombosis.

Key Complications of Abnormally Large Umbilical Cords

Excessively Long Umbilical Cord (ELUC)

Long umbilical cords (>70 cm, with excessive length typically defined as >100 cm) create substantial risk for mechanical complications and vascular obstruction. The research evidence demonstrates clear pathophysiologic mechanisms:

  • Fetal thrombotic vasculopathy (FTV): Long cords are strongly associated with massive FTV affecting >25% of placental mass, even without other cord abnormalities 1. The mechanism involves chronic vascular stasis leading to thrombosis formation 2, 3.

  • Intrauterine fetal demise (IUFD): Multiple case series document recurrent second-trimester pregnancy losses due to long, hypercoiled cords causing high-grade fetal vascular malperfusion 4. One series reported a 113-cm cord associated with massive FTV and stillbirth 1.

  • Mechanical entanglement: Long cords predispose to true knots, nuchal cords, and body entanglement. Studies show 61% of cases with FTV had clinical cord entanglement versus 24% without FTV 5.

Pathologic Mechanisms

The cascade of complications follows a predictable pattern:

  1. Vascular stasis from cord length/compression →
  2. Ectasia and distension of umbilical and chorionic vessels →
  3. Thrombosis formation in fetal vasculature →
  4. Avascular villi and fetal hypoxia →
  5. Growth restriction and/or fetal demise

Research demonstrates that placentas with gross cord abnormalities show significantly increased rates of:

  • Villous capillary congestion
  • Umbilical vessel distension
  • Fetal vascular thrombosis
  • Avascular villi
  • Intimal fibrin cushions 2, 3

Clinical Outcomes

The presence of long cords with histologic thrombosis significantly increases adverse outcomes:

  • Intrauterine growth restriction (IUGR): Significantly elevated in cases with both cord abnormalities and vascular thrombosis 3
  • Stillbirth: Gross cord abnormalities as a group are significantly associated with IUFD 2
  • Non-reassuring fetal heart tracings: Increased rates requiring emergency cesarean delivery 3
  • Meconium-stained fluid: More common with cord abnormalities 3

Associated Anatomic Anomalies

While excessively long cords can occur in isolation, they frequently coexist with:

  • Hypercoiling (umbilical coiling index >95th percentile): The combination of excessive length and hypercoiling appears particularly lethal, with documented recurrent pregnancy losses 4
  • True knots: More common with longer cords
  • Velamentous or marginal cord insertion: 30% of FTV cases had these insertions 5
  • Decreased Wharton's jelly: Creates additional vulnerability to compression 5

Thick/Wide Umbilical Cords

While the evidence focuses primarily on length, thick cords with excessive Wharton's jelly may indicate:

  • Gestational diabetes (maternal hyperglycemia)
  • Fetal macrosomia
  • Chromosomal abnormalities when combined with other markers

Conversely, narrow cords (<8 mm diameter) with diminished Wharton's jelly are associated with FTV and adverse outcomes 5.

Clinical Implications for Management

When a long or abnormal cord is identified:

  1. Increase surveillance intensity: Serial growth ultrasounds every 2-3 weeks, not the standard 3-4 weeks
  2. Umbilical artery Doppler assessment: Weekly monitoring for signs of vascular compromise 6, 7
  3. Assess for associated anomalies: Single umbilical artery carries 3-fold risk of SGA and 8-fold risk of stillbirth 6
  4. Pathologic examination is mandatory: All placentas with gross cord abnormalities require thorough histopathologic evaluation to document vascular changes 3

Critical Pitfalls

  • Do not dismiss isolated long cord as benign: Even without other abnormalities, ELUC alone can cause massive FTV and fetal death 1
  • Multiple cord abnormalities are cumulative: The presence of >1 cord abnormality significantly increases risk of non-reassuring fetal heart rate and chorangiosis 2
  • Genetic evaluation may be warranted: Recurrent cases of long, hypercoiled cords causing pregnancy loss suggest possible genetic etiology in some families 4

The evidence consistently demonstrates that large umbilical cords—whether excessively long or associated with other structural abnormalities—create substantial risk for fetal morbidity and mortality through vascular compromise, warranting heightened surveillance and thorough pathologic examination.

References

Research

Massive fetal thrombotic vasculopathy associated with excessively long umbilical cord and fetal demise: case report and literature review.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society, 2010

Research

Gross umbilical cord complications are associated with placental lesions of circulatory stasis and fetal hypoxia.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society, 2012

Research

Fetal Vascular Malperfusion Due To Long and Hypercoiled Umbilical Cords Resulting in Recurrent Second Trimester Pregnancy Loss: A Case Series and Literature Review.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.